摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-hydroxy-N-(1-(5-butylfur-2-yl)ethyl) urea

中文名称
——
中文别名
——
英文名称
N-hydroxy-N-(1-(5-butylfur-2-yl)ethyl) urea
英文别名
N-[1-(5-butyl-2-furyl)ethyl]-N-hydroxyurea;1-[1-(5-butylfuran-2-yl)ethyl]-1-hydroxyurea
N-hydroxy-N-(1-(5-butylfur-2-yl)ethyl) urea化学式
CAS
——
化学式
C11H18N2O3
mdl
——
分子量
226.276
InChiKey
YZFZZHNVTXWCDD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    79.7
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    1-(5-Butyl-furan-2-yl)-ethanone oxime 在 盐酸吡啶硼烷 作用下, 以 四氢呋喃1,4-二氧六环 为溶剂, 反应 2.17h, 生成 N-hydroxy-N-(1-(5-butylfur-2-yl)ethyl) urea
    参考文献:
    名称:
    Structure−Activity Relationships of N-Hydroxyurea 5-Lipoxygenase Inhibitors
    摘要:
    The discovery of second generation N-hydroxyurea 5-lipoxygenase inhibitors was accomplished through the development of a broad structure-activity relationship (SAR) study. This study identified requirements for improving potency and also extending duration by limiting metabolism. Potency could be maintained by the incorporation of heterocyclic templates substituted with selected lipophilic substituents. Duration of inhibition after oral administration was optimized by identification of structural features in the proximity of the N-hydroxyurea which correlated to low in vitro glucuronidation rates. Furthermore, the rate of in vitro glucuronidation was shown to be stereoselective for certain analogs. (R)-N-[3-[5-(4-Fluorophenoxy)-2-furyl]-1-methyl-2-propynyl]-N-hy- droxyurea (17c) was identified and selected for clinical development.
    DOI:
    10.1021/jm9700474
点击查看最新优质反应信息

文献信息

  • Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase
    申请人:ABBOTT LABORATORIES
    公开号:EP0320628B1
    公开(公告)日:1997-01-15
  • FURAN AND PYRROLE CONTAINING LIPOXYGENASE INHIBITING COMPOUNDS
    申请人:ABBOTT LABORATORIES
    公开号:EP0388429A1
    公开(公告)日:1990-09-26
  • EP0388429A4
    申请人:——
    公开号:EP0388429A4
    公开(公告)日:1991-08-21
  • US5112848A
    申请人:——
    公开号:US5112848A
    公开(公告)日:1992-05-12
  • WO1989004299A1
    申请人:——
    公开号:WO1989004299A1
    公开(公告)日:1989-05-18
查看更多